Serum uric acid <6.0 mg/dL at final visit · people with chronic gout
Febuxostat 120 mg/day probably leads to higher serum uric acid <6.0 mg/dL at final visit compared with allopurinol (moderate certainty).
1 finding from 1 review
Serum uric acid <6.0 mg/dL at final visit · people with chronic gout
Febuxostat 80 mg/day may leads to higher serum uric acid <6.0 mg/dL at final visit compared with placebo (low certainty).
1 finding from 1 review
Quality of sleep · patients with pain management in rheumatoid arthritis
1 finding from 1 review
Disability/Function (ASES) American Shoulder and Elbow Surgeons Shoulder Score. Scale from: 0 to 100 (Higher is better). · patients with Shoulder osteoarthritis
1 finding from 1 review
Intervention not reported
Muscle strength Isometric extension · patients with patients with Rheumatoid Arthritis
1 finding from 1 review
Intervention not reported
Muscle strength Isometric extension · patients with Rheumatoid Arthritis
1 finding from 1 review
Intervention not reported
Muscle strength Isometric extension · patients with Rheumatoid Arthritis
1 finding from 1 review
Pain(measured as proportion with pain) · children with asymptomatic flat feet
Custom foot orthoses showed no clear difference in pain(measured as proportion with pain) compared with prefabricated foot orthoses (low certainty).
1 finding from 1 review
RR 0.93 [0.73, 1.18]
Studies not reported
Low
Function or disability · children with asymptomatic flat feet
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life · children with asymptomatic flat feet
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Treatment success (caries lesion arrest or restoration survival) · children with asymptomatic flat feet
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Withdrawals due to adverse events · children with asymptomatic flat feet
Custom foot orthoses showed no clear difference in withdrawal due to adverse events compared with prefabricated foot orthoses (low certainty).
1 finding from 1 review
RR 1 [0.9, 1.12]
Studies not reported
Low
Adverse events · children with asymptomatic flat feet
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events · children with asymptomatic flat feet
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · children with juvenile idiopathic arthritis and flat feet
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Function or disability (measured on 0 to 100‐point FFI; 0 = no disability) · children with juvenile idiopathic arthritis and flat feet
1 finding from 1 review
no estimate extracted
Studies not reported
Low
QoL · children with juvenile idiopathic arthritis and flat feet
2 findings from 1 review
no estimate extracted
Studies not reported
Low
no estimate extracted
Studies not reported
Low
Treatment success (measured on the 50FWT (seconds)) · children with juvenile idiopathic arthritis and flat feet
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Withdrawals due to adverse events · children with juvenile idiopathic arthritis and flat feet
Custom foot orthoses showed no clear difference in withdrawal due to adverse events compared with prefabricated foot orthoses (low certainty).
1 finding from 1 review
RR 0.8 [0.13, 4.87]
Studies not reported
Low
Adverse effects · children with juvenile idiopathic arthritis and flat feet
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found